ArticleJournal of nanobiotechnology2025
Inverse-designed plasmonic biosensors with LSPR-SPP-wood anomaly coupling enhanced for biomolecular analysis.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasensitive, Selectivity Detection of Mercury Ion Using a Novel Localized Surface Plasmon Resonance Biosensor.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Investigating molecular interactions is crucial for advancing biological research and therapeutic discovery. Traditional analytical techniques often face limitations in sensitivity, quantification accuracy, and simplicity. Metasurfaces support resonances that are widely explored both for far-field wavefront shaping and for near-field sensing. Here, we introduce an innovative inverse-designed multilayer metasurface plasmon resonance (IDMM-SPR) sensor that overcomes these challenges. Using a double-objective optimization method that combines numerical simulations and machine learning, we developed an IDMM-SPR sensor featuring an optimized periodic nanocup array. This design yields unparalleled sensitivity and stability by harnessing collective resonances-including localized SPR, Wood's anomalies, and the Bloch wave SPR-which collectively enhance the sensing performance to enable the analysis of ultra-high affinity and low molecular weight interactions. The sensor achieves a figure of merit (FoM) of 26.3 and a detection limit (LOD) for C-reactive protein (CRP) as low as 0.84 ng/mL. Its compatibility with microplate absorbance readers and imaging detection makes it highly practical. The IDMM-SPR sensor shows exceptional promise for high-throughput direct molecular fishing, drug development, and disease diagnosis, offering a powerful tool for real-time, label-free affinity detection and quantitative analysis of biomolecular interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.